Back3D Global Biotech Overview

3D Global Biotech Long Term Debt

3D Global Biotech's long-term debt is $38M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$38.07M
↓ 50.91% YoYΔ $-39.49M vs prior year quarter

Peer trimmed avg / median

Loading

3D Global Biotech Long Term Debt History

Loading

3D Global Biotech vs. peers: Long Term Debt Comparison

Loading

3D Global Biotech Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

3D Global Biotech (6808.TWO) FAQ

3D Global Biotech (6808.TWO) currently reports a long-term debt of $38M as of June 2026. That compares with $78M in the prior-year period — down 50.9% year over year. Use the charts on this page to explore 3D Global Biotech's long-term debt history and peer comparisons.

3D Global Biotech's long-term debt decreased from $78M to $38M — a 50.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

3D Global Biotech reported $38M in long-term debt as of June 2026. That compares with $78M in the prior-year period — down 50.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $38M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for 3D Global Biotech, and consider following 6808.TWO for alerts when major investors trade the stock.

3D Global Biotech is classified in the Healthcare sector. On long-term debt, it currently shows $38M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6808.TWO with unrelated industries.